Retinoblastoma International - fighting children's eye cancerRetinoblastoma International - fighting children's eye cancer
  Early Diagnosis
Retinoblastoma International_Proteomics Proteomics
  Genetics / Testing and Counseling
  Prenatal/Neonatal Research and Aid
  Mexico Outreach

Retinoblastoma International - fighting children's eye cancer
Retinoblastoma International - fighting children's eye cancer
Retinoblastoma International - fighting children's eye cancer
Retinoblastoma International - fighting children's eye cancer

Make a Donation

 

Proteomics
(pro’-tee-om’-iks)

What is Proteomics?

The emerging field of Proteomics holds great promise for the early detection of cancer. Proteomics is the study of proteins and fragments of proteins (peptides) in the body and their relationship to disease. Specific patterns of proteins circulating in the blood can identify cancer in the same way fingerprints can identify people. These proteins, shed by cancer cells, are present in the blood, and can serve as indicators or “markers” of cancer. The Retinoblastoma Center at Childrens Hospital Los Angeles has embarked on an intensive effort to apply these principles to improve the early detection of retinoblastoma and other malignancies.

Why is Proteomics so important?

Children who have been diagnosed with bilateral retinoblastoma have an increased risk to develop non-ocular tumors, such as bone, and soft tissue cancer as well as melanoma throughout their lifetime. Unfortunately, for many types of cancer there are no adequate surveillance methods available to ensure early diagnosis and treatment among affected individuals and/or susceptible individuals. Many more children die from a retinoblastoma –associated malignancy than die from retinoblastoma. For this reason, there is a tremendous need to produce screening tests for various types of cancer that can assure the earliest possible diagnosis and treatment. Survival is directly related to early diagnosis.

What is the goal of the Proteomics Fund?

To date, Proteomics research has focused on common types of cancer that occur among adults. This approach does not address the needs of children with cancer, namely retinoblastoma. The goal of the Proteomics Fund is to jump-start the research on early detection of childhood cancers , with an emphasis on those that threaten survivors of retinoblastoma. Retinoblastoma will be the first childhood tumor studied in this landmark program. When this work is successful, proteomics-based early detection will be extended to other childhood cancers.

Retinoblastoma International_Proteomics Foundation

How can I be a part of this important research?

The Proteomics Fund was founded by the parents of Rory Anne, a brave little girl diagnosed with bilateral retinoblastoma by Dr. Murphree at Childrens Hospital Los Angeles. For this reason, all payments can go directly to the RBI-Proteomics Fund. It is important to label them with "Proteomics Fund" so that they go directly to this important research.

VIEW, E-MAIL, OR PRINT A 2-PAGE PROTEOMICS FUNDRAISING BROCHURE

CONTACT US TO FOR INFORMATION ON A TRIFOLD PROTEOMICS FUNDRAISING BROCHURE
(for best results, this file tri-fold brochure should be reproduced by a professional printing service)

Use PayPal to make a donation online to the RBI - Proteomics Fund!
Donation Amount:
$


Double your contribution if your employer has a Matching Gift Program! (more info)

Or, please make your check payable to "RBI - Proteomics Fund" and send it to:

Retinoblastoma International
4650 Sunset Boulevard MS #88
Los Angeles, CA 90027

Thank you very much for your support!
BACK TO TOP OF PAGE

Retinoblastoma International
c/o Children's Hospital Los Angeles
4650 Sunset Boulevard MS #88, Los Angeles, CA 90027
323-361-2299

info@retinoblastoma.net

MAP | DIRECTIONS
Web Design by Mission TC and ichobiz